Premium
Bevacizumab‐induced hand‐foot syndrome: circumscribed type
Author(s) -
Munehiro A.,
Yoneda K.,
Nakai K.,
Demitsu T.,
Moriue T.,
Moriue J.,
Yokoi I.,
Fujita N.,
Matsuura N.,
Ishikawa S.,
Yokomise H.,
Kubota Y.
Publication year - 2010
Publication title -
british journal of dermatology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2010.09716.x
Subject(s) - medicine , bevacizumab , carboplatin , docetaxel , erlotinib , lung cancer , sunitinib , oncology , vinorelbine , chemotherapy , gemcitabine , surgery , cancer , epidermal growth factor receptor , cisplatin